What form is required for transferring CII stock to a medical office?

The correct form required for transferring Schedule II (CII) stock to a medical office is the DEA 222 form. This form is specifically designed for the purchase and transfer of controlled substances categorized under Schedule II, which includes drugs with a high potential for abuse and dependence. The DEA 222 form serves as a legal document that tracks the distribution and receipt of these substances, ensuring compliance with federal regulations.

When a pharmacy or distributor needs to transfer CII medications to a medical office, they must provide a completed DEA 222 form to document the transaction. This record-keeping is vital for maintaining control and accountability of controlled substances, which is a major focus of the Drug Enforcement Administration to prevent misuse and illegal diversion.

Other forms listed, such as an invoice, prescription record, or transfer notice, do not fulfill the regulatory requirements for CII transfers. While invoices may be used for general inventory and purchase records, they do not specifically account for the stringent regulations surrounding CII substances. Thus, using the DEA 222 form is essential to remain compliant with federal laws regarding the handling of controlled substances.